354390.KQ Alginomics, Inc. (알지노믹스) Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
03:01
Apr 20
Apr 20
Alginomics liver-cancer combo shows complete response.
Alginomics presented at AACR on an RNA-based liver-cancer combination therapy that achieved complete response. The speaker had previously flagged it for attention and says the news is being rewarded as part of the current biotech news-sensitive market.
MED
About 354390.KQ Investor Commentary
Across the available history and selected sources, Buzzberg tracks 354390.KQ (Alginomics, Inc. (알지노믹스)) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Lee Kwon-hee.